Vaginal Mesh Is Not Inert Resulting in Ongoing Damage to Muscles and Nerves

Polypropylene mesh causes acute, chronic inflammation that cause pelvic floor myalgia, hip adductor myalgia (groin pain), pudendal and obturator neuralgia

We are also representing clients with… injuries caused by both TOT sling devices and transvaginal mesh devices used in the treatment of pelvic organ prolapse. ”

— Dr. Greg Vigna

SANTA BARBARA, CA, UNITED STATES, July 11, 2020 /EINPresswire.com/ — The polypropylene mesh of transobturator (TOT) slings, commonly used in the surgical management of stress urinary incontinence (SUI), are designed to pass into the groin and through the thigh to provide a hammock-like support to the urethra. During the blind implantation procedure, the arms of the mesh pierce the obturator internus muscle and gracilis muscle, and anatomical studies prove that it passes into the adductor brevis muscle 25% of the time and adductor longus muscle 75% of the time as the arms of the sling pass out of the both thighs. Unfortunately, polypropylene mesh is not inert and causes acute and chronic inflammation that cause pelvic floor myalgia (muscle pain), hip adductor myalgia (groin pain), and pudendal and obturator neuralgia.

Acute pain mechanisms following implantation include injury to the muscles of the pelvis and groin, direct injury to the obturator nerve, and indirect compression or traction to the obturator and pudendal nerves from muscles spasms related to muscle injuries from the mesh and trocars. Obturator nerve injury or irritation results in groin pain, hip pain, and sometimes numbness or burning on the inner thigh. The pudendal nerve becomes irritated by compression or traction by spasm of the obturator internus muscle that is anatomically adjacent to the pudendal nerve as the nerve passes from the spine into the pelvis. Pudendal nerve irritation causes a variety of symptoms which may include severe perineum pain, inability to wear tight pants, clitoral numbness or pain, constipation, tailbone pain, dyspareunia (pain with vaginal intercourse), constipation, and painful bladder filling.

Unfortunately, polypropylene is not inert and leads to nonanatomic pathological state that has the potential to cause new onset, insidious pain sometimes years after implants. Following mesh implantation there is life-time inflammation to the muscles and soft tissues of the pelvis and groin caused by mesh that results in excessive scarification, contraction and shrinkage of the mesh, and perpetual oxidative radical formation within the hypoxic interface between the mesh and healthy pelvic tissue. These pathological states occur in all women with vaginal mesh and provides the biological nexus between pain from nerves and muscles, Complex Regional Pain Syndrome, and pudendal neuralgia and obturator neuralgia by compression and/or traction. Latent injuries to the pudendal and obturator nerves occur years after implantation by way of compression and traction resulting in pudendal neuralgia and obturator neuralgia.

TOT slings have arms that pass through multiple compartments of the pelvis and thigh, piercing muscles at various angles along the way creating a non-anatomical state. TOT slings are NOT tension free as claimed by the manufacturers as the arms are often densely adhered to bone, often requiring bone cutters or ruggers to cut the mesh off the bone. Tension is created between adjacent vital structures of the leg and pelvis connected by the mesh which is exacerbated by ongoing scarification, shrinkage of the mesh, and the perpetual inflammation. Any of these mechanisms may cause traction injuries and compression injuries to nerves and muscle pain (myalgia) sometimes developing years after implantation.

Greg Vigna, MD, JD, national pharmaceutical injury attorney, practicing physician, and Certified Life Care Planner states, “Unlike abdominal hernia surgery where the mesh is placed in the fascial planes above or below the abdominal muscles, TOTs are designed to pierce and cross the muscles of the pelvis and leg in non-anatomical fashion whereby these structures are harpooned by the mesh causing foreseeable and unavoidable acute pain from muscles and nerves that sometimes is life-altering and is poorly responsive to mesh removal and treatment.”

Dr. Vigna adds, “We are also representing clients with new injuries from recently implanted devices and those that occur years after implantation caused by both TOT sling devices and transvaginal mesh devices used in the treatment of pelvic organ prolapse. We are filing these cases nationwide with the assistance of local attorneys.”

Dr. Vigna is a California and Washington DC lawyer who focuses on catastrophic neurological injuries caused by transvaginal mesh devices including pudendal neuralgia, obturator neuralgia, ilioinguinal neuralgia, and Complex Regional Pain Syndrome. He has clients filed around the country with Martin Baughman, a Dallas Texas firm. Ben Martin and Laura Baughman are national pharmaceutical injury trial attorneys in Dallas, Texas.

For articles, video resources, and information visit the Pudendal Neuralgia Educational Portal and click here for information regarding sling related complications. We also offer a FREE BOOK on Vaginal Mesh Pain.

Greg Vigna, MD, JD
Vigna Law Group
1155 Coast Village Rd., Suite 3, Santa Barbara, CA
1-800-761-9206

Reference: https://pubmed.ncbi.nlm.nih.gov/30045054/

Greg Vigna
Greg Vigna, M.D., J.D., PLC
+1 800-761-9206
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Hospice Care is Changing Amidst the Pandemic According to Kenneth Haglind

Kenneth Haglind Minnesota Hospice

Kenneth Haglind Discusses How Hospice Care is Evolving with COVID-19 Cases

LAKEVILLE, MINNESOTA, UNITED STATES, July 10, 2020 /EINPresswire.com/ — The COVID-19 pandemic has led to tens of thousands of people being infected around the country. The senior communities are being greatly impacted by the pandemic particularly, leading to hospice care experiencing more pressure than ever before. Ken Haglind, the president of Minnesota Hospice in Lakeville, Minnesota has identified what some of the new changes are.

Kenneth Haglind recommends identifying the resources available to care for someone who has been diagnosed with the coronavirus, particularly if they are a senior citizen. When there are added health concerns with a patient, the disease can be deadly. As such, a higher level of support is needed.

Further, Ken Haglind suggests that the caregivers be careful about their interactions with a patient. When a caregiver is responsible for multiple patients in hospice care, it can lead to accidental exposure of other patients. All it takes is for one patient to have COVID-19 for all of the other patients under the care of the caregiver to be at a higher risk.

Ken Haglind identifies that there are hospice care teams that are exploring symptom management and communicating as new protocols are released from the CDC. Families are also told to be on the lookout for specific symptoms, including fevers, shortness of breath, and a dry cough.

In some instances, elderly individuals who are suspected of having COVID-19 are being refused by hospitals due to insufficient support. Hospice facilities, however, are working to provide comfort packs so that families can care for the sick without risking added exposure being admitted into a hospital.

Kenneth Haglind has modeled Minnesota Hospice under the vision of creating a gold standard for end-of-life care. Additionally, he works to create an environment where caregivers get the support and resources that they need.

With COVID-19, many details are evolving quickly. Kenneth Haglind’s goal is to provide correct information to caregivers and hospice care workers as it is released so that everyone is working together. This includes identifying new symptoms as the virus mutates as well as identifying levels of care. When it looks as though a patient will not recover, it becomes all about providing the most comfortable atmosphere possible. The mission of hospice that never changes is to make sure that the quality of life at the end of one’s life is the primary goal. Comfort, dignity, and choice are afforded to those who are served by hospice.

Anyone who has a loved one who has been diagnosed with COVID-19 or is suspected of having the virus should contact a local hospice to find out what support is being offered in their community, recommends Ken Haglind.

Caroline Hunter
Web Presence, LLC
+1 786-233-8220
email us here


Source: EIN Presswire

MEDICAL MARIJUANA: A CLINICAL HANDBOOK Provides Up-to-Date Insights on the Science of Cannabis and Its Medicinal Use

Medical Marijuana:  A Clinical Handbook book cover

Medical Marijuana: A Clinical Handbook

Medical Marijuana:  A Clinical Handbook back cover

Medical Marijuana: A Clinical Handbook

This timely medical marijuana clinical handbook is the most comprehensive and best book on the topic.”

— Stephen Ross, MD, NYU Grossman School of Medicine

NEW YORK, NY, UNITED STATES, July 10, 2020 /EINPresswire.com/ — A new textbook, Medical Marijuana: A Clinical Handbook (Wolters Kluwer, September 2020), provides an objective look at the history and science of the plant and strips away the cultural and political baggage that often clouds any meaningful examination of cannabis's therapeutic value.

The authors, Drs. Samoon Ahmad and Kevin P. Hill, wrote the book to provide clinicians with the most accurate information available on cannabis and empower them to give their patients the best advice on treatment. Cannabis continues to be the single most misunderstood plant on Earth. It has been cultivated and used for thousands of years yet remains not just enigmatic but deeply polarizing.

"Both sides of the argument often fail to see through the fog of the culture war, and both sides are at times guilty of being more intent on winning a political argument than approaching the issue with a clear head and an agenda couched solely in the tradition of empiricism and science," Drs. Ahmad and Hill write in Medical Marijuana. "This book hopes to change that."

Both authors have extensive clinical experience and impressive resumes. Dr. Hill is an addiction specialist and currently Director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center in Boston, an Associate Professor of Psychiatry at Harvard University, and author of Marijuana: The Unbiased Truth About the World's Most Popular Weed. Dr. Ahmad is a practicing physician in New York City, Founder of the Integrative Center for Wellness, and a Professor of Psychiatry at NYU Grossman School of Medicine. He has also written extensively about PTSD and coauthored multiple books, including recent editions of Kaplan & Sadock's Pocket Handbook of Clinical Psychiatry and Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment.

The authors focus on tetrahydrocannabinol (THC), which is the intoxicating substance in cannabis and typically the focal point of medical marijuana programs. They also examine the relevant science on many other cannabinoids found in the plant, especially cannabidiol (CBD). Included in the book is detailed analysis of local and federal laws governing the use of cannabis and a state-by-state guide for clinicians and patients. They have also created a companion website, cannabistextbook.com, that will monitor changes to local, state, and federal regulations as they occur, and share recently published cannabis-related research.

"This timely medical marijuana clinical handbook is the most comprehensive and best book on the topic in my opinion," said Stephen Ross, M.D., Associate Professor of Psychiatry and Director of the Addictive Disorders and Experimental Therapeutics Research Laboratory at NYU Grossman School of Medicine. "Excellently written, the book provides an enormous amount of concise and clinically relevant information on everything related to medical cannabis including historical and regulatory aspects, the dizzying diversity of the many cannabis constituent components, review of the endocannabinoid system, relevant pharmacology, therapeutic preparations and the existing and potential clinical applications of medical cannabis throughout medicine, psychiatry and neurology."

The book enables clinicians to easily find information that is pertinent to specific body systems and disciplines. It also provides a wealth of information about the plant itself. The book begins by examining its classification, morphology, history and constituents. It then moves on to a cultural history of cannabis in the United States to provide a context for the regulations and laws currently governing its use. The book then describes the body's endocannabinoid system and the pharmacological profile of CBD and THC before moving on to specific applications for cannabis in specialty practices such as:

Endocrinology
Oncology
Gastroenterology
Neurology
Psychiatry
Gynecology
Rheumatology
Internal medicine
Ophthalmology
Hepatology
Dermatology

Finally, the authors describe the dangers of excessive cannabis use and potential adverse effects.

"It is our hope that we can eliminate unwarranted stigmas that continue to hound this quirky plant and to dispel any notions that cannabis is either a miracle drug or the devil's weed," the authors write. "If nothing else, we hope to provide our peers in the medical community with some degree of clarity so that they can make decisions based on the best available evidence and pass on accurate information to [their] patients."

About the Authors

Samoon Ahmad, M.D. is Professor in the Department of Psychiatry at NYU Grossman School of Medicine and serves as Unit Chief of Bellevue Medical Center's Inpatient Unit. A practicing physician for over twenty-five years, Dr. Ahmad has dedicated his professional life to helping individuals find balance in their mental and physical well-being. He founded the Integrative Center for Wellness to execute his innovative vision of incorporating psychiatric treatments with holistic therapies—including nutritional therapy, yoga, meditation, acupuncture, and plant-based medicines—to emphasize wellness of both the body and the mind. He specializes in treating patients with depression, anxiety, bipolar disorder, ADHD, stuttering, and weight management issues.

Kevin P. Hill, M.D., M.H.S. is an addiction psychiatrist and Director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center and Associate Professor of Psychiatry at Harvard Medical School. Dr. Hill has conducted clinical research and written on a wide variety of topics including medical cannabis, cannabidiol (CBD), and addiction to alcohol, cannabis, and opioids. As a leading cannabis expert, he has spoken nationally and appeared often on radio and television on the topics of cannabis policy and treatment, offering a balanced, evidence-based stance on these issues.

Reviews

"Drs. Ahmad and Hill are to be congratulated on producing a book that is a complete and thorough guide to cannabis, is most timely and highly informative, and will appeal to a large audience."

-Benjamin Sadock, MD, Menas S. Gregory Professor of Psychiatry at the NYU Grossman School of Medicine and NYU Langone Health

"This timely medical marijuana clinical handbook is the most comprehensive and best book on the topic."

-Stephen Ross, MD, Director of the Addictive Disorders and Experimental Therapeutics Research Laboratory and Associate Professor of Psychiatry at NYU Grossman School of Medicine

"The authors have written an extremely comprehensive book that will give readers
a more nuanced appreciation of cannabis. This includes its potential therapeutic value, its effects on the endocannabinoid system, and the parts it has played in cultures throughout the world."

-Joyce Cenali, Founding Partner & COO of Big Rock Partners, a strategic advisory firm

"Though written primarily for healthcare practitioners and clinicians,
anyone hoping to gain a greater understanding about cannabis and its therapeutic applications
will find this work extremely informative and helpful."

-Marion Mariathasan, CEO of Simplifya, the leading regulatory and compliance software platform serving the cannabis industry

Medical Marijuana: A Clinical Handbook
By Samoon Ahmad, M.D., and Kevin P. Hill, M.D., M.H.S.

Publisher: Wolters Kluwer
Publication Date: September 2020
Price: $69.99
ISBN: 9781975141899

Joe Flattery
kmacconnect
+1 917-474-2689
email us here


Source: EIN Presswire

MEDICAL MARIJUANA: A CLINICAL HANDBOOK The Most Up-to-Date Insights on the Science of Cannabis and Its Medicinal Use

Medical Marijuana:  A Clinical Handbook book cover

Medical Marijuana: A Clinical Handbook

Medical Marijuana:  A Clinical Handbook back cover

Medical Marijuana: A Clinical Handbook

This timely medical marijuana clinical handbook is the most comprehensive and best book on the topic.”

— Stephen Ross, MD, NYU Grossman School of Medicine

NEW YORK, NY, UNITED STATES, July 10, 2020 /EINPresswire.com/ — A new textbook, Medical Marijuana: A Clinical Handbook (Wolters Kluwer, September 2020), provides an objective look at the history and science of the plant and strips away the cultural and political baggage that often clouds any meaningful examination of cannabis's therapeutic value.

The authors, Drs. Samoon Ahmad and Kevin P. Hill, wrote the book to provide clinicians with the most accurate information available on cannabis and empower them to give their patients the best advice on treatment. Cannabis continues to be the single most misunderstood plant on Earth. It has been cultivated and used for thousands of years yet remains not just enigmatic but deeply polarizing.

"Both sides of the argument often fail to see through the fog of the culture war, and both sides are at times guilty of being more intent on winning a political argument than approaching the issue with a clear head and an agenda couched solely in the tradition of empiricism and science," Drs. Ahmad and Hill write in Medical Marijuana. "This book hopes to change that."

Both authors have extensive clinical experience and impressive resumes. Dr. Hill is an addiction specialist and currently Director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center in Boston, an Associate Professor of Psychiatry at Harvard University, and author of Marijuana: The Unbiased Truth About the World's Most Popular Weed. Dr. Ahmad is a practicing physician in New York City, Founder of the Integrative Center for Wellness, and a Professor of Psychiatry at NYU Grossman School of Medicine. He has also written extensively about PTSD and coauthored multiple books, including recent editions of Kaplan & Sadock's Pocket Handbook of Clinical Psychiatry and Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment.

The authors focus on tetrahydrocannabinol (THC), which is the intoxicating substance in cannabis and typically the focal point of medical marijuana programs. They also examine the relevant science on many other cannabinoids found in the plant, especially cannabidiol (CBD). Included in the book is detailed analysis of local and federal laws governing the use of cannabis and a state-by-state guide for clinicians and patients. They have also created a companion website, cannabistextbook.com, that will monitor changes to local, state, and federal regulations as they occur, and share recently published cannabis-related research.

"This timely medical marijuana clinical handbook is the most comprehensive and best book on the topic in my opinion," said Stephen Ross, M.D., Associate Professor of Psychiatry and Director of the Addictive Disorders and Experimental Therapeutics Research Laboratory at NYU Grossman School of Medicine. "Excellently written, the book provides an enormous amount of concise and clinically relevant information on everything related to medical cannabis including historical and regulatory aspects, the dizzying diversity of the many cannabis constituent components, review of the endocannabinoid system, relevant pharmacology, therapeutic preparations and the existing and potential clinical applications of medical cannabis throughout medicine, psychiatry and neurology."

The book enables clinicians to easily find information that is pertinent to specific body systems and disciplines. It also provides a wealth of information about the plant itself. The book begins by examining its classification, morphology, history and constituents. It then moves on to a cultural history of cannabis in the United States to provide a context for the regulations and laws currently governing its use. The book then describes the body's endocannabinoid system and the pharmacological profile of CBD and THC before moving on to specific applications for cannabis in specialty practices such as:

Endocrinology
Oncology
Gastroenterology
Neurology
Psychiatry
Gynecology
Rheumatology
Internal medicine
Ophthalmology
Hepatology
Dermatology

Finally, the authors describe the dangers of excessive cannabis use and potential adverse effects.

"It is our hope that we can eliminate unwarranted stigmas that continue to hound this quirky plant and to dispel any notions that cannabis is either a miracle drug or the devil's weed," the authors write. "If nothing else, we hope to provide our peers in the medical community with some degree of clarity so that they can make decisions based on the best available evidence and pass on accurate information to [their] patients."

About the Authors

Samoon Ahmad, M.D. is Professor in the Department of Psychiatry at NYU Grossman School of Medicine and serves as Unit Chief of Bellevue Medical Center's Inpatient Unit. A practicing physician for over twenty-five years, Dr. Ahmad has dedicated his professional life to helping individuals find balance in their mental and physical well-being. He founded the Integrative Center for Wellness to execute his innovative vision of incorporating psychiatric treatments with holistic therapies—including nutritional therapy, yoga, meditation, acupuncture, and plant-based medicines—to emphasize wellness of both the body and the mind. He specializes in treating patients with depression, anxiety, bipolar disorder, ADHD, stuttering, and weight management issues.

Kevin P. Hill, M.D., M.H.S. is an addiction psychiatrist and Director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center and Associate Professor of Psychiatry at Harvard Medical School. Dr. Hill has conducted clinical research and written on a wide variety of topics including medical cannabis, cannabidiol (CBD), and addiction to alcohol, cannabis, and opioids. As a leading cannabis expert, he has spoken nationally and appeared often on radio and television on the topics of cannabis policy and treatment, offering a balanced, evidence-based stance on these issues.

Reviews

"Drs. Ahmad and Hill are to be congratulated on producing a book that is a complete and thorough guide to cannabis, is most timely and highly informative, and will appeal to a large audience."

-Benjamin Sadock, MD, Menas S. Gregory Professor of Psychiatry at the NYU Grossman School of Medicine and NYU Langone Health

"This timely medical marijuana clinical handbook is the most comprehensive and best book on the topic."

-Stephen Ross, MD, Director of the Addictive Disorders and Experimental Therapeutics Research Laboratory and Associate Professor of Psychiatry at NYU Grossman School of Medicine

"The authors have written an extremely comprehensive book that will give readers
a more nuanced appreciation of cannabis. This includes its potential therapeutic value, its effects on the endocannabinoid system, and the parts it has played in cultures throughout the world."

-Joyce Cenali, Founding Partner & COO of Big Rock Partners, a strategic advisory firm

"Though written primarily for healthcare practitioners and clinicians,
anyone hoping to gain a greater understanding about cannabis and its therapeutic applications
will find this work extremely informative and helpful."

-Marion Mariathasan, CEO of Simplifya, the leading regulatory and compliance software platform serving the cannabis industry

Medical Marijuana: A Clinical Handbook
By Samoon Ahmad, M.D., and Kevin P. Hill, M.D., M.H.S.

Publisher: Wolters Kluwer
Publication Date: September 2020
Price: $69.99
ISBN: 9781975141899

Joe Flattery
kmacconnect
+1 917-474-2689
email us here


Source: EIN Presswire

Volunteers from around the world participate in GGHTx Avi Kerendian project to help vulnerable in Mexico and Africa

avikerendian-uganda-GGHTx-clinic-medical-Zidan

avikerendian-uganda-GGHTx-clinic-medical-Zidan

Avi Kerendian GGHTx Global Health Nonprofit Logo

Avi Kerendian GGHTx Global Health Nonprofit Logo

avikerendian-uganda-GGHTx-clinic-medical-Zidan

Brushing teeth GGHTx clinic in Mexico

Avi Kerendian is the nonprofit co-founder and program director of GGHTx. GGHTx is a global health NGO on a mission in changing global health outcomes.

Happiness doesn't result from what you get, but from what you give. Volunteer on our next GGHTx Global Health mission trip today!”

— Avi Kerendian

HOUSTON, TEXAS, UNITED STATES, July 10, 2020 /EINPresswire.com/ — Doctors and dentists from around the world will be able to participate in a telemedicine project to help the most vulnerable communities in Latin America and Africa

The initiative, led by North American directors Avi Kerendian and Dr. Arash Hakhamian, founders of the international program "Thank you, Global Health Trips" (GGHTx), seeks to recruit doctors and dentists from around the world, who are interested in living a life experience Unforgettable, contributing your knowledge and talents to the less fortunate, through the use of technology.

The project is carried out in partnership with Dentulu, an app that connects doctors and dentists with patients, regardless of where in the world they are. Thanks to this application, patients will be able to receive medical advice by video call and schedule a face-to-face medical visit in the closest place, at no cost.

This initiative arises from the current world situation generated by the COVID-19 pandemic, in which it becomes more complex to move and provide medical care in person, as the GGHTx program has been doing for several years in international medical missions .

Thanks to telemedicine, it will be possible to continue the work of helping the less fortunate with free and dignified medical care in third world countries.

How does the Gracias, Global Health Trips (GGHTx) program operate?
Since its foundation, the “Thank you, Global Health Trips” (GGHTx) program has led medical and dental care projects in person in remote places where medical care is poor or absent. Some of the countries that have traveled in these medical missions are Mexico, El Salvador, Peru and Costa Rica.

During the trips, the volunteers provide medical and dental care to the locals, while providing them with more complex medicines and treatments. All this financed by donors or sponsors who make their contributions through the program's website: https://gghtx.org/
Anyone anywhere in the world can be a donor and support this cause.

How to participate in the Thank you program, Global Health Trips (GGHTx)?
Volunteers are recruited through a strict process, in which their medical skills and criminal records are validated. Subsequently, the founding doctors of the program carry out a virtual interview to learn a little more about the candidate and her interest in joining this initiative.

Once the volunteer is selected, a previous training is carried out in the headquarters of New York and Los Angeles, in the United States, where they receive all the information about the place of visit, culture, customs and medical needs of the population.

For volunteers, this experience is more than an international medical mission. It is a life experience, full of learning and emotions. From the first day of arrival in the town, the volunteers take in the culture and the warmth of the locals.

The working day runs from 8 in the morning until 2 in the afternoon, and afterwards, they have a free space for fun and guided tours of the places of interest, to delve into the wonderful experience that Latin American countries offer.

For director Avi Kerendian, co-founder of the “Thank You, Global Health Trips” Program (GGHTx), this volunteer program is for someone who wants an experience that challenges you on a daily basis, gives you an opportunity to encourage and help others, but also have fun and learn from a new culture. "You will never have a dull moment here, I can assure you," says Kerendian.

¿Qué opinan los voluntarios del programa “Gracias, Global Health Trips” (GGHTx)?
"Tuve el privilegio de pasar una semana con GGHTx en su última misión médica. Visitamos muchas aldeas rurales e indígenas y me maravillé con las pequeñas clínicas médicas que apoya el programa GGHTx, ¡es tanto el impacto con tan pocos recursos! Realmente recomiendo este viaje a cualquiera que quiera ser voluntario y ver cómo es trabajar en otro país. ¡Es increíble poder tener una oportunidad como esta y estoy muy feliz y honrado de tener estos recuerdos para siempre!". Jordana R. (Houston, Texas)

Otros proyectos que abandera GGHTx
Como parte de su misión de extender ayuda médica gratuita a poblaciones remotas y vulnerables, “Gracias, Global Health Trips” (GGHTx) también apoya programas de educación en África, en alianza con Zidan Benevolence Internacional.

El último proyecto realizado en Uganda, denominado The Stigma Project”, buscaba generar conciencia frente al VIH/Sida, una enfermedad que sigue cobrando vidas en esta región, principalmente, por su alto desconocimiento y falta de educación entre la población.

The Stigma Project realizó jornadas de educación, prevención y conciencia, en niños y jóvenes en el distrito de Buikwe, centro de Uganda, con el fin de inspirar el liderazgo y empoderamiento de la comunidad, y ayudar a eliminar el estigma que existe alrededor de esta enfermedad.
Toda la información sobre este proyecto, se puede consultar en https://gghtx.org/upcoming-projects

Avi Kerendian
Avi Kerendian GGHTx
+1 323-496-2272
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

A 3 PART SERIES ON A NOVEL GLOBAL HEALTH APPROACH USING BEHAVIORAL THEORY (GGHTx, Avi Kerendian)


Source: EIN Presswire

Dr. David Samadi breaks down the stages of COVID-19 and best practices for treatment

Early detection, Intervention and treatment of Covid 19 is very critical. Different stages of this disease requires different treatments. Dr. Samadi

Early Detection of Covid 19 is the key, sooner treatment and intervention can happen the higher chance of recovery.The video describes different treatment options available to patients with covid 19”

— Dr. David Samadi

NEW YORK, NEW YORK, UNITED STATES, July 10, 2020 /EINPresswire.com/ — COVID-19 has proved to be a formidable enemy that has taken too many lives unnecessarily. From the beginning, when our understanding of this novel coronavirus was limited, it proved to be a tough contender to fight off. Fortunately, through numerous studies along with trial and error, our doctors and scientists have gained a tremendous amount of knowledge on how best to fight this deadly foe. When the stages of this viral infection are broken down, it becomes clearer on the best practices needed to win this fight.

Dr. David Samadi, Director of Men’s Health and Urologic Oncology at St. Francis Hospital on Long Island, New York, has written extensively on COVID-19 since the lockdown began in March. As a urologist and surgeon, he’s emphasized the same way he treats prostate cancer early on before it advances complicating treatment and survival rates, is the same way this virus should be treated.

“Like any disease, early detection and early intervention of treating it to prevent spread of the virus, is the way to go and is ultimately key in reducing mortality,” exclaimed Dr. Samadi. “If you have symptoms, be proactive. Get tested as soon as possible. If you test positive, prevent this virus from taking control by starting treatment early on.”

To help understand the stages of COVID-19 and what treatments are recommended, Dr. Samadi has broken the advancement of COVID-19 into 3 stages: Stage 1 is when the virus is beginning to ramp up creating a lot of inflammation.

“At stage one, this is when a person may have symptoms of a fever, chills, shortness of breath, chest pain, and body aches,” explained Dr. Samadi. “At this very beginning stage, it’s important to start a treatment of providing an antiobiotic of either amoxicillin or z-pak helping prevent bacterial pneumonia.”

Reducing inflammation during stage one is critical to prevent a cytokine storm which is the most dangerous and potentially life-threatening event related to COVID-19. For stage one, Dr. Samadi also recommends zinc, hydroxychloroquine, and a bronchodilator such as Budesonide helping open up the lungs to reduce inflammation helping a person breathe better while fighting off the virus. Preliminary data also shows that Ivermectin in this early stage could be very effective.

Stage two is called viral replication or duplication. At this stage, the virus begins to replicate and duplicate throughout the body affecting many different organs.

“In this stage, the best medication available is remdesivir,” said Dr. Samadi. “This medication reduces the replication of the virus by blocking the RNA polymerase, a key enzyme the virus needs to replicate its genetic material to proliferate or multiply in our body. If it’s blocked, it essentially stops the spread. For young adults who’ve died from the virus, often from blood clots or stroke, blood thinning medications are now advised and recommended for those in this age category”

People hovering between stage 2 and stage 3, may also benefit from using convalescent plasma. “Plasma is the largest part of your blood making up about 55 percent of its overall content,” explained Dr. Samadi. “People who have recovered from COVID-19 develop antibodies which are found in plasma. Studies have found that plasma removed from these patients with antibodies, referred to as convalescent plasma, can be beneficial for some patients with severe COVID-19 boosting their ability to fight off the virus.”

If a person advances on to stage 3, multiple organ failure affecting the kidneys, heart, and lungs, has occurred. At this point, the prognosis is poor of only 20-30% of patients who reach this stage will recover. Back in March and April, placing these patients on ventilators was widespread. Since then and because of the poor prognosis once patients were ventilated, physicians have questioned their use stating that these patients could instead be treated with less intensive respiratory support.

“Studies show that instead of automatically relying on ventilators which take over the breathing for the patient, to instead consider placing patients who’ve advanced to stage three on dexamethasone which can reduce the risk of death by 30%,” said Dr. Samadi. “Mechanical ventilation is an invasive traumatic treatment and comes with risks such as severe lung damage. We now know that ventilators are not the right treatment for coronavirus.”

“I personally have added a stage 4 to recovery from COVID-19,” exclaimed Dr. Samadi. “The power of prayer. As a surgeon, I’ve operated on thousands and thousands of patients with prostate cancer with robotic surgery. My own personal belief and faith in God has been my guide as I take care of these men. As a result, I’ve had very, very low complications or issues with my patients. While I would like to take the credit, I know it belongs to this omnipotent power that takes over when we reach out in prayer. It’s helped me this far and I plan on continuing to use it.”

Dr. David Samadi is the Director of Men’s Health and Urologic Oncology at St. Francis Hospital in Long Island. He’s a renowned and highly successful board certified Urologic Oncologist Expert and Robotic Surgeon in New York City, regarded as one of the leading prostate surgeons in the U.S., with a vast expertise in prostate cancer treatment and Robotic-Assisted Laparoscopic Prostatectomy. Visit Dr. Samadi’s websites at robotic oncology and prostate cancer 911.

david b samadi
roboticoncology
+1 2123655000
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Different stages of Corona Virus and treatment option Dr. Samadi’s Conslusion


Source: EIN Presswire

WCG to Host July 16 Blood Drive in Colorado Springs

tax consultants

July 16 Blood Drive

WCG, a tax and accounting firm in Colorado Springs, is hosting a mobile blood drive on July 16, in partnership with Vitalant.

The country needs blood now more than ever.”

— Tina Watson

COLORADO SPRINGS, COLORADO, UNITED STATES, July 10, 2020 /EINPresswire.com/ — WCG Inc., located in Colorado Springs’ Flying Horse neighborhood, is hosting a community blood drive on Thursday, July 16, 2020. The group of tax consultants is partnering with First National Bank of Monument, The Club at Flying Horse and Vitalant to provide a safe and convenient way to donate blood. According to Vitalant, “Hundreds of blood drives have been canceled across the country resulting in a loss of more than 130,000 units of blood.”

Tina Watson, CPA, founding Partner of WCG, “The country needs blood now more than ever. More people are in the hospital and fewer people are donating blood.”

Per Vitalant’s questions and answers, “blood donation does not impact or weaken a donor’s immune system.” They continue in response to safety, “our staff follow rigorous safety and disinfection protocols at all blood drives and donation centers. These include wearing gloves and personal protective gear, wiping down donor-touched areas after every collection, using sterile single-use collection sets for every donation/collection, and arm scrubbing for 30 seconds.” They are also requiring all donors to wear a mask during collection.

Vitalant will also be testing for COVID-19 antibodies and will alert donors with the results through their donor portal. Eligible blood donors are encouraged to read safety information provided by WCG and Vitalant, and also schedule a donor time on Thursday, July 16. Both are available on WCG’s website at wcginc.com/drive. Should scheduling difficulties arise, please contact WCG directly for assistance.

WCG is also an official Care and Share drop-off location. Donors are encouraged to bring non-perishable food items as part of their blood donation.

Jason Watson
WCG
+ +1 719-428-3261
email us here
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

Sign up TODAY for Weekly Georgia-Focused Commentaries

Betsy DeVos opens the 2020 Georgia Legislative Policy Forum with "An Education Conversation." Register today to attend via Zoom

Betsy DeVos opens the 2020 Georgia Legislative Policy Forum with “An Education Conversation.” Register today to attend via Zoom

Top-Rated Nonprofit

The Foundation has been ranked a Top-Rated Nonprofit by Greatnonprofits.org

Georgia Public Pollicy Foundation's regular op-eds share ideas, Georgia-specific solutions and policy updates

The Think Tanks and Civil Society Program has ranked the Foundation as one of the “Best Independent Think Tanks” in its Global Go-To Think Tank Index”

— Georgia Public Policy Foundation

ATLANTA, GA, UNITED STATES, July 10, 2020 /EINPresswire.com/ — The Georgia Public Policy Foundation distributes a weekly commentary (opinion editorial) for publication by news outlets across the state, at no charge, provided the author and his/her affiliations are cited.

Established in 1991, the Foundation is a trusted, independent resource for voters and elected officials, providing actionable solutions to real-life problems by bringing people together. State-focused, independent, non-partisan and market-oriented in its approach, the Foundation conducts scholarly research and analysis of state public policy issues, and works to educate citizens, policy-makers and the media.

Among recent commentaries:

June 26, 2020: "Foundation Adapts, with 2020's Georgia Legislative Policy Forum on Zoom," by Benita M. Dodd.
After several successful Zoom events, the Foundation decided that, instead of surrendering to COVID-19, the 2020 Georgia Legislative Policy Forum will adapt. It will be hosted on Zoom as a series of weekly webinars.
July 3, 2020: "Legislature Acts to Increase Transparency in Drug Pricing," by Chris Denson
Among the healthcare legislation passed in the waning days that should be highlighted and commended is a bill intended to better regulate how pharmacy benefit managers operate.

The Think Tanks and Civil Society Program has ranked the Foundation as one of the “Best Independent Think Tanks” in its Global Go-To Think Tank Index. Regular events include Leadership Breakfasts and Policy Briefing Luncheons. Weekly publications are the Friday Facts and Friday Idea commentaries.

Sign up here to be added to the Foundation's media mailing list and receive news releases, commentaries and event updates and invitations.

Benita Dodd
Georgia Public Policy Foundation
+1 404-483-0661
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Computed Tomography (CT) Scan Market Major Manufacturers, Trends, Demand, Share Analysis to 2026

New Study Reports "Computed Tomography (CT) Scan Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added.

PUNE, MAHARASHTRA, INDIA, July 10, 2020 /EINPresswire.com/ — Computed Tomography (CT) Scan Market 2020-2026

New Study Reports "Computed Tomography (CT) Scan Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports.

Introduction/Report Summary:

This report provides in depth study of “Computed Tomography (CT) Scan Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Computed Tomography (CT) Scan Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

A computed tomography (CT or CAT) scan allows doctors to see inside your body.

Drivers and Constraints

The fundamental dynamics that are explored in the report hold substantial influence over the Computed Tomography (CT) Scan market. The report further studies on the value, volume trends, and the pricing history of the market. In addition to it, various growth factors, restraints, and opportunities are also analyzed for the market to study the in-depth understanding of the market.

This report also analyzes the impact of Coronavirus COVID-19 on the Computed Tomography (CT) Scan industry.

Key Players

The report has profiled some of the Important players prevalent in the global like – Siemens (Germany), GE Healthcare (UK),
Toshiba (Japan)
Hitachi (Japan)
Philips (Netherlands)
Shimadzu (Japan), and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the Computed Tomography (CT) Scan.

Request for Free Sample Report of “Computed Tomography (CT) Scan” Market @  https://www.wiseguyreports.com/sample-request/5561521-global-computed-tomography-ct-scan-market-insights-and-forecast-to-2026

Market Segmentation based On Type, Application and Region:

The global Computed Tomography (CT) Scan is analyzed for different segments to arrive at an insightful analysis. Such segmentation has been done based on type, application, and region.

Based on Type, the global Computed Tomography (CT) Scan Market is segmented into X-Ray Computed Tomography (CT), Ultrasonic Computed Tomography (CT), Gamma Rays CT and other

Based on Application, the Computed Tomography (CT) Scan Market is segmented into Hospital, Physical Examination Center, and Others.

Based on Detailed Regional Analysis, the regional segmentation has been carried out for regions of U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report on WGR includes an in-depth study of the Computed Tomography (CT) Scan in each regional segment mentioned above.

Key Stakeholders 
Computed Tomography (CT) Scan Market Manufacturers 
Computed Tomography (CT) Scan Market Distributors/Traders/Wholesalers 
Computed Tomography (CT) Scan Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/5561521-global-computed-tomography-ct-scan-market-insights-and-forecast-to-2026

Major Key Points from Table of Content:

1 Study Coverage
1.1 Computed Tomography (CT) Scan Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Computed Tomography (CT) Scan Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Computed Tomography (CT) Scan Market Size Growth Rate by Type
1.4.2 X-Ray Computed Tomography (CT)
1.4.3 Ultrasonic Computed Tomography (CT)
1.4.4 Gamma Rays CT
1.5 Market by Application
1.5.1 Global Computed Tomography (CT) Scan Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Physical Examination Center
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Computed Tomography (CT) Scan Market Size, Estimates and Forecasts
2.1.1 Global Computed Tomography (CT) Scan Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Computed Tomography (CT) Scan Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Computed Tomography (CT) Scan Production Estimates and Forecasts 2015-2026
2.2 Global Computed Tomography (CT) Scan, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Computed Tomography (CT) Scan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Computed Tomography (CT) Scan Manufacturers Geographical Distribution
2.4 Key Trends for Computed Tomography (CT) Scan Markets & Products
2.5 Primary Interviews with Key Computed Tomography (CT) Scan Players (Opinion Leaders)

8 Corporate Profiles
8.1 Siemens (Germany)
8.1.1 Siemens (Germany) Corporation Information
8.1.2 Siemens (Germany) Overview
8.1.3 Siemens (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Siemens (Germany) Product Description
8.1.5 Siemens (Germany) Related Developments
8.2 GE Healthcare (UK)
8.2.1 GE Healthcare (UK) Corporation Information
8.2.2 GE Healthcare (UK) Overview
8.2.3 GE Healthcare (UK) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 GE Healthcare (UK) Product Description
8.2.5 GE Healthcare (UK) Related Developments
8.3 Toshiba (Japan)
8.3.1 Toshiba (Japan) Corporation Information
8.3.2 Toshiba (Japan) Overview
8.3.3 Toshiba (Japan) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Toshiba (Japan) Product Description
8.3.5 Toshiba (Japan) Related Developments
8.4 Hitachi (Japan)
8.4.1 Hitachi (Japan) Corporation Information
8.4.2 Hitachi (Japan) Overview
8.4.3 Hitachi (Japan) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Hitachi (Japan) Product Description
8.4.5 Hitachi (Japan) Related Developments

and more

Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Continued…

Contact Us:

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Medical Shoe Covers – Global Sales, Price, Revenue, Gross Margin And Market Share Forecast Outlook Till 2026

PUNE, INDIA, INDIA, July 10, 2020 /EINPresswire.com/ —  

COVID-19 Impact on Global Medical Shoe Covers Market – 2020-2026

 

***Updated Free Sample Report Is Ready To Dispatch

 

Summary: Medical Shoe Covers Market

This report denotes a committed and all-inclusive assessment of the present comparisons documented in the Medical Shoe Covers Market. It delivers an articulate brief, which gets in sync the viewpoint of the report in the Medical Shoe Covers Market, its efficacies, as well as the dealings that are in employment. The Medical Shoe Covers Market's experience is prepared by the specialist's examination of the market circumstance, and the significant industry developments in the remarkable regions of the market share. Likewise, the Medical Shoe Covers Market report makes it simple to advance to the working expenditure limitations of the product and the succeeding pressures encountered by the connections in the Medical Shoe Covers Market. The international Medical Shoe Covers Market report presents a comprehensive evidence flow of the different inspirations that are intensifying the Medical Shoe Covers Market. The report facilitates the reporting of the market state and the forecast period up to 2026.

Free Sample Report PDF: COVID-19 Impact on Global Medical Shoe Covers Market Outlook @

https://www.wiseguyreports.com/sample-request/5438501-global-medical-shoe-covers-market-insights-forecast-to-2026?utm_medium=Jiten-10.7&utm_source=PR

 

Understanding the segments helps in identifying the importance of different factors that aid the

Drivers and Risks

The report also calls to the focus of work tendencies inside the market as well as the appraisals in addition to assembling comprehension into the operative traces on behalf of the Medical Shoe Covers Market. A buildup of potential extension stages, forces, and estimations are also revealed to get a much-adjusted explanation of the Medical Shoe Covers Market's progress.

Regional Description

The region-wise estimation of the Medical Shoe Covers Market has a renowned intent of checking the market constituent of expansion and classifying the forecasts regarding progress, which are apparent through the known regions. The report also evaluates the regions such as Europe, Asia Pacific, Latin America, North America, and the MEA with the reexamination of the Medical Shoe Covers Market for the approaching years. The hesitations decelerating the Medical Shoe Covers Market predispositions are arranged with all these regions to transmit into line the structures of the latest trends, perspective, and settings validated in the appraisal period concluding in 2026. The investigation of the Medical Shoe Covers Market observes many regions on an international stage, where the greatest transactions have implications concentrated on positive returns through alliances in only specific regions.

 

View Complete Report / Any Query @

https://www.wiseguyreports.com/reports/5438501-global-medical-shoe-covers-market-insights-forecast-to-2026?utm_medium=Jiten-10.7&utm_source=PR

Key Market Trends | Growth | Share | Sale | Revenue | Manufactures | Technology Component

Method of Research

The investigation of the market comprises of the methods of its primary pressures, areas, and selections. Also, the establishments, using the SWOT based on which the review is made adroit at presenting careful opinions about the Medical Shoe Covers Market. To provide widespread inspection, the Medical Shoe Covers Market is divided on the basis of a coalition of forces at work that is reviewed in Porter's Five Force Model in the period ahead.

Key Players

The report adds the concentration on the market's experience along with the tendencies mutable in the purview. The report centres on the latest sellers in the market segments, which displays the chief participants' input to the Medical Shoe Covers Market.

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

What are the key segments in the market?

By product type
By End User/Applications
By Technology
By Region

 

Which market dynamics affect the business?

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Table of Content: Covid-19 Impact On Medical Shoe Covers Market

 

1 Study Coverage

2 Executive Summary 

3 Breakdown Data by Manufacturers 

4 Breakdown Data by Type 

5 Breakdown Data by Application 

11 Company Profiles 

12 Future Forecast 

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 

14 Value Chain and Sales Channels Analysis 

15 Research Findings and Conclusion

16 Appendix 

Continued …

Download Free Sample Copy @

https://www.wiseguyreports.com/sample-request/5438501-global-medical-shoe-covers-market-insights-forecast-to-2026?utm_medium=Jiten-10.7&utm_source=PR

NOTE : Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

About Us:

“Wise Guy Reports Is Part of the Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data for Industries and Governments Around the Globe. Wise Guy Reports Features an Exhaustive List of Market Research Reports from Hundreds of Publishers Worldwide. We Boast a Database Spanning Virtually Every Market Category and an Even More Comprehensive Collection of Market Research Reports Under These Categories and Sub-Categories”.

CONTACT US:

NORAH TRENT
Wise Guy Reports
+162 825 80070
email us here


Source: EIN Presswire